Gene: GPSM3
Official Full Name: G protein signaling modulator 3provided by HGNC
Gene Summary: Predicted to enable GTPase regulator activity. Predicted to be involved in positive regulation of inflammatory response. Predicted to act upstream of or within positive regulation of cytokine production involved in inflammatory response and positive regulation of leukocyte chemotaxis. Predicted to be located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20167 | GPSM3 Knockout cell line (HeLa) | Human | GPSM3 | 1:3~1:6 | Negative | Online Inquiry |
KO20168 | GPSM3 Knockout cell line (HCT 116) | Human | GPSM3 | 1:2~1:4 | Negative | Online Inquiry |
GPSM3 Gene Knockout Cell Lines represent a revolutionary tool for researchers seeking to elucidate the functional roles of the GPSM3 gene in various biological processes. These genetically engineered cell lines have been specifically designed to lack the GPSM3 gene, allowing for a comprehensive study of its involvement in cell signaling pathways, differentiation, and disease mechanisms.
The primary function of GPSM3 gene knockout cell lines is to facilitate the understanding of the gene's contributions to cellular responses. By using CRISPR-Cas9 technology, these cells are created to ensure precise, heritable gene edits that result in the complete loss of GPSM3 expression. This knockout model allows researchers to observe consequential phenotypic changes that may arise in terms of cell proliferation, migration, and response to external stimuli. The ability to isolate the GPSM3 gene provides insights into its role as a regulator of multiple signaling pathways, including those implicated in cancer, metabolism, and neurodevelopment.
In scientific research and clinical applications, GPSM3 knockout cell lines serve as invaluable resources for drug discovery, biomarker identification, and the development of targeted therapies. By providing a relevant model for studying the pathological roles of GPSM3, these cell lines enable innovative approaches to developing therapeutic interventions tailored to conditions where GPSM3 dysregulation is implicated.
What sets GPSM3 Gene Knockout Cell Lines apart from alternatives is their reliability, efficiency, and ease of use. Unlike traditional methods of gene silencing, such as RNA interference, which can lead to transient knockdown effects, these knockout cell lines provide stable and consistent data across experiments. Moreover, they promote a swift transition from basic research to translational applications, thereby expediting the pace of scientific discovery.
Investing in GPSM3 Gene Knockout Cell Lines allows researchers and clinicians to advance their understanding of complex biological systems and drives forward precision medicine initiatives. With our extensive expertise in gene editing and commitment to delivering high-quality biological products, we ensure that our offerings empower scientists to achieve groundbreaking results in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.